B-BRIDGE Trademark

Trademark Overview


On Monday, August 21, 2006, a trademark application was filed for B-BRIDGE with the United States Patent and Trademark Office. The USPTO has given the B-BRIDGE trademark a serial number of 76664863. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 20, 2015. This trademark is owned by B-Bridge International, Inc.. The B-BRIDGE trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Biosciences research products, namely, biochemical mechanisms used for research in the nature of transfection products, namely, quickstep transfection kit comprised of transfection reagents, for research purposes; Polymerase Chain Reaction (PCR) products, enzymes and reagents, namely, Taq deoxyribonucleic acid (DNA) Polymerase, Hot Start DNA Polymerase, deoxynucleotide triphosphate (dNTP) solutions, namely, sets of all four dNTPs 2'-Deoxyadenosine 5'-Triphosphate (dATP), 2'-Deoxycytidine 5'-Triphosphate (dCTP), 2'-Deoxyguanosine 5'-Triphosphate (dGTP), and 2'-Deoxythymidine 5'-Triphosphate (dTTP)), and Real Time PCR Kits comprised of chemicals, namely, DNA polymerase, Globin mixture containing glycerol, potassium chloride (KCl), dATP, dCTP, dGTP, dTTP and primers, magnesium chloride (MgCl2), reagents, and blood for research purposes; nucleic acid purification products, namely, plasmid DNA isolation kits comprised of chemicals, namely, transfection reagents for research purposes, ribonu...

Biological research, consulting, and analytical services, provided by scientists, in the nature of analysis of chemicals and biological sequences, sample analysis, ribonucleic acid (RNA) design in the nature of polymer design, small interfering ribonucleic acid (siRNA) design, siRNA synthesis in the nature of synthesis of polymers for scientific research, biological research of cells, cell strain, biochemical mechanisms, antibodies and proteins, apoptosis detection, cell culture, clones, food, and nucleic acid purification; providing of chemical laboratory facilities
b-bridge

General Information


Serial Number76664863
Word MarkB-BRIDGE
Filing DateMonday, August 21, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 20, 2015
Registration Number3486764
Registration DateTuesday, August 19, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2008

Trademark Statements


Goods and ServicesBiosciences research products, namely, biochemical mechanisms used for research in the nature of transfection products, namely, quickstep transfection kit comprised of transfection reagents, for research purposes; Polymerase Chain Reaction (PCR) products, enzymes and reagents, namely, Taq deoxyribonucleic acid (DNA) Polymerase, Hot Start DNA Polymerase, deoxynucleotide triphosphate (dNTP) solutions, namely, sets of all four dNTPs 2'-Deoxyadenosine 5'-Triphosphate (dATP), 2'-Deoxycytidine 5'-Triphosphate (dCTP), 2'-Deoxyguanosine 5'-Triphosphate (dGTP), and 2'-Deoxythymidine 5'-Triphosphate (dTTP)), and Real Time PCR Kits comprised of chemicals, namely, DNA polymerase, Globin mixture containing glycerol, potassium chloride (KCl), dATP, dCTP, dGTP, dTTP and primers, magnesium chloride (MgCl2), reagents, and blood for research purposes; nucleic acid purification products, namely, plasmid DNA isolation kits comprised of chemicals, namely, transfection reagents for research purposes, ribonucleic acid (RNA) purification kits comprised of chemicals, namely, transfection reagents for research purposes, and high throughput purification kits comprised of chemicals, namely, buffers and buffers for lysis, binding, wash and elute, and mannitol-adenine-phosphate (MAP) solution containing mannitol, adenine and crystalline sodium dihydrogen phosphate for research purposes; apoptosis detection kits comprised of reagents for research purposes and chemicals consisting of buffers, fixatives, and biochemical stains; diabetes and obesity research products, namely, chemicals in the nature of human and mouse/rat adiponectin, resistin, leptin, and leptin-receptor enzyme-linked immunosorbent assay (ELISA) kits comprised of chemicals and anti-human leptin-receptor, wash buffer, recombinant human leptin-receptor, assay diluent, biotinylated anti-human leptin-receptor, concentrated horseradish peroxidase (HRP)-conjugated streptavidin, tetramethylbenzidine (TMB), and sulfuric acid substances for research purposes, and human endogenous secreted receptor for advanced glycation end products (esRAGE); ELISA kit comprised of chemicals in the nature of sulfuric acid, plate with absorbed anti-RAGE antibody, esRAGE intibody-horseradish peroxidase conjugated as Detection Antibody, 3,3', 5, 5'-tetramethylbenzidine and hydrogen peroxide, phosphate buffered saline containing bovine serum albumin, human esRAGE, phosphate buffered saline with Tween 20, for research purposes; interfering ribonucleic acid (RNAi) products, namely, small interfering RNA (siRNA) reagents for scientific research purpose, and GeneNet siRNA libraries and sequences in the nature of polymers for screening genome-wide for genes regulating cellular responses or signaling pathways, identifying potential drug targets or diagnostic markers that inhibit, enhance, or activate a selectable phenotype and finding crucial regulatory genes using routine growth selections or flow sorting; cell culture products, namely, chemicals in the nature of visceral adipocytes, epididymal adipocytes, subcutaneous adipocytes, and osteoclasts; chemicals for use in scientific research preparations, namely, full open reading frame (ORF) clones, full-length clones, sequence verified clones, and genomic clones for applications in protein expression, functional genomics, and functional analysis
Goods and ServicesBiological research, consulting, and analytical services, provided by scientists, in the nature of analysis of chemicals and biological sequences, sample analysis, ribonucleic acid (RNA) design in the nature of polymer design, small interfering ribonucleic acid (siRNA) design, siRNA synthesis in the nature of synthesis of polymers for scientific research, biological research of cells, cell strain, biochemical mechanisms, antibodies and proteins, apoptosis detection, cell culture, clones, food, and nucleic acid purification; providing of chemical laboratory facilities

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 20, 2015
Primary Code001
First Use Anywhere DateThursday, November 2, 2000
First Use In Commerce DateThursday, January 3, 2002

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 20, 2015
Primary Code042
First Use Anywhere DateThursday, November 2, 2000
First Use In Commerce DateThursday, January 3, 2002

Trademark Owner History


Party NameB-Bridge International, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Party NameB-Bridge International, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Party NameB-Bridge International, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events


Event DateEvent Description
Friday, March 20, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, August 19, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, June 3, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 14, 2008NOTICE OF PUBLICATION
Wednesday, April 30, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 30, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 30, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, April 30, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 30, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, April 30, 2008EXAMINERS AMENDMENT -WRITTEN
Friday, March 14, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 14, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 25, 2008NON-FINAL ACTION MAILED
Friday, February 22, 2008NON-FINAL ACTION WRITTEN
Thursday, January 31, 2008ASSIGNED TO EXAMINER
Wednesday, January 16, 2008WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, January 16, 2008TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, November 1, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, October 29, 2007WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, October 16, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 15, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 12, 2007EXAMINERS AMENDMENT MAILED
Thursday, October 11, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, October 11, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 11, 2007AMENDMENT FROM APPLICANT ENTERED
Tuesday, September 11, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 7, 2007PAPER RECEIVED
Monday, August 27, 2007FINAL REFUSAL MAILED
Monday, August 27, 2007FINAL REFUSAL WRITTEN
Thursday, August 2, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, August 2, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 2, 2007ASSIGNED TO LIE
Thursday, July 19, 2007PAPER RECEIVED
Monday, April 23, 2007NON-FINAL ACTION MAILED
Sunday, April 22, 2007NON-FINAL ACTION WRITTEN
Tuesday, March 27, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 26, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 26, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2007COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Friday, January 26, 2007EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
Friday, January 26, 2007EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, January 16, 2007ASSIGNED TO EXAMINER
Tuesday, August 29, 2006APPLICATION FILING RECEIPT MAILED
Friday, August 25, 2006NEW APPLICATION ENTERED IN TRAM